Daryoush Hamidi Alamdari, PhD
3 clinical trials · Sponsor
◉ Watch Daryoush Hamidi Alamdari, PhD
| Record | Firm | Date |
|---|---|---|
| Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue (NCT07311070) | Daryoush Hamidi Alamdari, PhD | 2025-10-21 |
Track Daryoush Hamidi Alamdari, PhD automatically
Every clearance here is in the API, with alerts when new ones post.